|
|
|
|
||
Haven't seen this posted yetSorrento Announces Dosing of COVID-19 Patients in Phase 2 Clinical Trial for COVIDROPS, a Highly Potent Neutralizing Antibody Against SARS-CoV-2 Including Delta and Alpha Variants of Concern, in an At-Home Outpatient Setting in United Kingdom https://investors.sorrentotherapeutics.com/news-releases |
return to message board, top of board |